2023-02-012024-01-312024-01-31false07483216CONFIDENTS DENTURE CLINIC LIMITED2024-10-15iso4217:GBPxbrli:pure074832162023-02-01074832162024-01-31074832162023-02-012024-01-31074832162022-02-01074832162023-01-31074832162022-02-012023-01-3107483216bus:SmallEntities2023-02-012024-01-3107483216bus:AuditExempt-NoAccountantsReport2023-02-012024-01-3107483216bus:FullAccounts2023-02-012024-01-3107483216bus:PrivateLimitedCompanyLtd2023-02-012024-01-3107483216core:WithinOneYear2024-01-3107483216core:AfterOneYear2024-01-3107483216core:WithinOneYear2023-01-3107483216core:AfterOneYear2023-01-3107483216core:ShareCapital2024-01-3107483216core:SharePremium2024-01-3107483216core:RevaluationReserve2024-01-3107483216core:OtherReservesSubtotal2024-01-3107483216core:RetainedEarningsAccumulatedLosses2024-01-3107483216core:ShareCapital2023-01-3107483216core:SharePremium2023-01-3107483216core:RevaluationReserve2023-01-3107483216core:OtherReservesSubtotal2023-01-3107483216core:RetainedEarningsAccumulatedLosses2023-01-3107483216core:LandBuildings2024-01-3107483216core:PlantMachinery2024-01-3107483216core:Vehicles2024-01-3107483216core:FurnitureFittings2024-01-3107483216core:OfficeEquipment2024-01-3107483216core:NetGoodwill2024-01-3107483216core:IntangibleAssetsOtherThanGoodwill2024-01-3107483216core:ListedExchangeTraded2024-01-3107483216core:UnlistedNon-exchangeTraded2024-01-3107483216core:LandBuildings2023-01-3107483216core:PlantMachinery2023-01-3107483216core:Vehicles2023-01-3107483216core:FurnitureFittings2023-01-3107483216core:OfficeEquipment2023-01-3107483216core:NetGoodwill2023-01-3107483216core:IntangibleAssetsOtherThanGoodwill2023-01-3107483216core:ListedExchangeTraded2023-01-3107483216core:UnlistedNon-exchangeTraded2023-01-3107483216core:LandBuildings2023-02-012024-01-3107483216core:PlantMachinery2023-02-012024-01-3107483216core:Vehicles2023-02-012024-01-3107483216core:FurnitureFittings2023-02-012024-01-3107483216core:OfficeEquipment2023-02-012024-01-3107483216core:NetGoodwill2023-02-012024-01-3107483216core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3107483216core:ListedExchangeTraded2023-02-012024-01-3107483216core:UnlistedNon-exchangeTraded2023-02-012024-01-3107483216core:MoreThanFiveYears2023-02-012024-01-3107483216core:Non-currentFinancialInstruments2024-01-3107483216core:Non-currentFinancialInstruments2023-01-3107483216dpl:CostSales2023-02-012024-01-3107483216dpl:DistributionCosts2023-02-012024-01-3107483216core:LandBuildings2023-02-012024-01-3107483216core:PlantMachinery2023-02-012024-01-3107483216core:Vehicles2023-02-012024-01-3107483216core:FurnitureFittings2023-02-012024-01-3107483216core:OfficeEquipment2023-02-012024-01-3107483216dpl:AdministrativeExpenses2023-02-012024-01-3107483216core:NetGoodwill2023-02-012024-01-3107483216core:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3107483216dpl:GroupUndertakings2023-02-012024-01-3107483216dpl:ParticipatingInterests2023-02-012024-01-3107483216dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-01-3107483216core:ListedExchangeTraded2023-02-012024-01-3107483216dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-01-3107483216core:UnlistedNon-exchangeTraded2023-02-012024-01-3107483216dpl:CostSales2022-02-012023-01-3107483216dpl:DistributionCosts2022-02-012023-01-3107483216core:LandBuildings2022-02-012023-01-3107483216core:PlantMachinery2022-02-012023-01-3107483216core:Vehicles2022-02-012023-01-3107483216core:FurnitureFittings2022-02-012023-01-3107483216core:OfficeEquipment2022-02-012023-01-3107483216dpl:AdministrativeExpenses2022-02-012023-01-3107483216core:NetGoodwill2022-02-012023-01-3107483216core:IntangibleAssetsOtherThanGoodwill2022-02-012023-01-3107483216dpl:GroupUndertakings2022-02-012023-01-3107483216dpl:ParticipatingInterests2022-02-012023-01-3107483216dpl:GroupUndertakingscore:ListedExchangeTraded2022-02-012023-01-3107483216core:ListedExchangeTraded2022-02-012023-01-3107483216dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-02-012023-01-3107483216core:UnlistedNon-exchangeTraded2022-02-012023-01-3107483216core:NetGoodwill2024-01-3107483216core:IntangibleAssetsOtherThanGoodwill2024-01-3107483216core:LandBuildings2024-01-3107483216core:PlantMachinery2024-01-3107483216core:Vehicles2024-01-3107483216core:FurnitureFittings2024-01-3107483216core:OfficeEquipment2024-01-3107483216core:AfterOneYear2024-01-3107483216core:WithinOneYear2024-01-3107483216core:ListedExchangeTraded2024-01-3107483216core:UnlistedNon-exchangeTraded2024-01-3107483216core:ShareCapital2024-01-3107483216core:SharePremium2024-01-3107483216core:RevaluationReserve2024-01-3107483216core:OtherReservesSubtotal2024-01-3107483216core:RetainedEarningsAccumulatedLosses2024-01-3107483216core:NetGoodwill2023-01-3107483216core:IntangibleAssetsOtherThanGoodwill2023-01-3107483216core:LandBuildings2023-01-3107483216core:PlantMachinery2023-01-3107483216core:Vehicles2023-01-3107483216core:FurnitureFittings2023-01-3107483216core:OfficeEquipment2023-01-3107483216core:AfterOneYear2023-01-3107483216core:WithinOneYear2023-01-3107483216core:ListedExchangeTraded2023-01-3107483216core:UnlistedNon-exchangeTraded2023-01-3107483216core:ShareCapital2023-01-3107483216core:SharePremium2023-01-3107483216core:RevaluationReserve2023-01-3107483216core:OtherReservesSubtotal2023-01-3107483216core:RetainedEarningsAccumulatedLosses2023-01-3107483216core:NetGoodwill2022-02-0107483216core:IntangibleAssetsOtherThanGoodwill2022-02-0107483216core:LandBuildings2022-02-0107483216core:PlantMachinery2022-02-0107483216core:Vehicles2022-02-0107483216core:FurnitureFittings2022-02-0107483216core:OfficeEquipment2022-02-0107483216core:AfterOneYear2022-02-0107483216core:WithinOneYear2022-02-0107483216core:ListedExchangeTraded2022-02-0107483216core:UnlistedNon-exchangeTraded2022-02-0107483216core:ShareCapital2022-02-0107483216core:SharePremium2022-02-0107483216core:RevaluationReserve2022-02-0107483216core:OtherReservesSubtotal2022-02-0107483216core:RetainedEarningsAccumulatedLosses2022-02-0107483216core:AfterOneYear2023-02-012024-01-3107483216core:WithinOneYear2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:CostValuation2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-012024-01-3107483216core:Non-currentFinancialInstrumentscore:CostValuation2024-01-3107483216core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-3107483216core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-3107483216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-3107483216core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-3107483216core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-3107483216core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-3107483216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-3107483216core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-3107483216core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3107483216core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3107483216core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3107483216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3107483216core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3107483216core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3107483216core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3107483216core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3107483216core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3107483216bus:Director12023-02-012024-01-31

CONFIDENTS DENTURE CLINIC LIMITED

Registered Number
07483216
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2024

CONFIDENTS DENTURE CLINIC LIMITED
Company Information
for the year from 1 February 2023 to 31 January 2024

Director

MORRIS, Phillip Anthony

Registered Address

19 Albert Road
Harborne
Birmingham
B17 0AP

Registered Number

07483216 (England and Wales)
CONFIDENTS DENTURE CLINIC LIMITED
Statement of Financial Position
31 January 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets33,7604,423
3,7604,423
Current assets
Cash at bank and on hand29,68347,480
29,68347,480
Creditors amounts falling due within one year4(26,988)(23,367)
Net current assets (liabilities)2,69524,113
Total assets less current liabilities6,45528,536
Creditors amounts falling due after one year5(5,333)(9,333)
Provisions for liabilities6(940)(840)
Net assets18218,363
Capital and reserves
Called up share capital22
Profit and loss account18018,361
Shareholders' funds18218,363
The financial statements were approved and authorised for issue by the Director on 15 October 2024, and are signed on its behalf by:
MORRIS, Phillip Anthony
Director
Registered Company No. 07483216
CONFIDENTS DENTURE CLINIC LIMITED
Notes to the Financial Statements
for the year ended 31 January 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery15
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 February 2318,68818,688
At 31 January 2418,68818,688
Depreciation and impairment
At 01 February 2314,26514,265
Charge for year663663
At 31 January 2414,92814,928
Net book value
At 31 January 243,7603,760
At 31 January 234,4234,423
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables9241,585
Bank borrowings and overdrafts4,0004,000
Taxation and social security10,50114,293
Other creditors11,5633,489
Total26,98823,367
5.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts5,3339,333
Total5,3339,333
6.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)940840
Total940840